Researchers from Cancer Research United Kingdom Cambridge Institute have recently developed an innovative breath test. Which has now been launched into a clinical trial to assess if it can detect multiple forms of cancer?
The noninvasive test screens for the presence of volatile organic compounds (VOCs). These are molecules found in the patients breath and could alert the presence of cancer. With this new technology, we could see the diagnosis of cancer at very early stages, allowing people to access treatment quickly enhancing the probability of positive health outcomes.
The new breath test, called Owlstone Medical's Breath Biopsy, is being assessed in a clinical trial called the PAN Cancer Trial for Early Detection of Cancer in Breath.
Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer.